These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36701402)

  • 1. Correction: Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
    PLOS ONE Staff
    PLoS One; 2023; 18(1):e0281190. PubMed ID: 36701402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.
    Chantarangsu S; Cressey TR; Mahasirimongkol S; Capparelli E; Tawon Y; Ngo-Giang-Huong N; Jourdain G; Lallemant M; Chantratita W
    J Antimicrob Chemother; 2009 Dec; 64(6):1265-73. PubMed ID: 19812066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    Chambal LM; Samo Gudo E; Carimo A; Corte Real R; Mabunda N; Maueia C; Vubil A; Zicai AF; Bhatt N; Antunes F
    PLoS One; 2017; 12(12):e0190460. PubMed ID: 29267379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
    Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
    PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi.
    Palombi L; Galluzzo CM; Andreotti M; Liotta G; Jere H; Sagno JB; Luhanga R; Mancinelli S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2015 Oct; 70(10):2881-4. PubMed ID: 26111981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
    Jourdain G; Ngo-Giang-Huong N; Le Coeur S; Bowonwatanuwong C; Kantipong P; Leechanachai P; Ariyadej S; Leenasirimakul P; Hammer S; Lallemant M;
    N Engl J Med; 2004 Jul; 351(3):229-40. PubMed ID: 15247339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 and HIV-2 antibodies in pregnant women in the City of Maputo, Mozambique. A comparative study between 1982/1983 and 1990.
    Barreto J; Liljestrand J; Palha de Sousa C; Bergström S; Böttiger B; Biberfeld G; De la Cruz F
    Scand J Infect Dis; 1993; 25(6):685-8. PubMed ID: 8052807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
    Deiss R; Loreti CV; Gutierrez AG; Filipe E; Tatia M; Issufo S; Ciglenecki I; Loarec A; Vivaldo H; Barra C; Siufi C; Molfino L; Antabak NT
    PLoS One; 2024; 19(2):e0298877. PubMed ID: 38330095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
    Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A;
    Lancet Infect Dis; 2013 Apr; 13(4):303-12. PubMed ID: 23433590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Pregnancy intention and contraceptive use among HIV-positive Malawian women at 4-26 weeks post-partum: A nested cross-sectional study.
    Thindwa D; Landes M; van Lettow M; Kanyemba A; Nkhoma E; Phiri H; Kalua T; van Oosterhout JJ; Kim EJ; Tippett Barr BA;
    PLoS One; 2019; 14(5):e0217330. PubMed ID: 31120981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.
    Kunz A; Frank M; Mugenyi K; Kabasinguzi R; Weidenhammer A; Kurowski M; Kloft C; Harms G
    J Antimicrob Chemother; 2009 Jan; 63(1):170-7. PubMed ID: 18974161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique.
    Vaz P; Augusto O; Bila D; Macassa E; Vubil A; Jani IV; Pillon R; Sandstrom P; Sutherland D; Giaquinto C; Jordan MR; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S369-74. PubMed ID: 22544205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission.
    Flys TS; McConnell MS; Matovu F; Church JD; Bagenda D; Khaki L; Bakaki P; Thigpen MC; Eure C; Fowler MG; Eshleman SH
    J Infect Dis; 2008 Aug; 198(4):465-9. PubMed ID: 18582198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique.
    Micek MA; Dross S; Blanco AJ; Beck IA; Matunha L; Seidel K; Montoya P; Matediana E; Gantt S; Gloyd S; Frenkel L
    J Infect Dis; 2014 Aug; 210(4):641-5. PubMed ID: 24596282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    Chambal LM; Gudo ES; Carimo A; Corte Real R; Mabunda N; Maueia C; Vubil A; Zicai AF; Bhatt N; Antunes F
    PLoS One; 2017; 12(7):e0181836. PubMed ID: 28759595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of HIV Prevention of Mother-To-Child Transmission Programs in Sub-Saharan Africa: Longitudinal Assessment of 64 Nevirapine-Based Programs Implemented in 25 Countries, 2000-2011.
    Ladner J; Besson MH; Rodrigues M; Saba J; Audureau E
    PLoS One; 2015; 10(6):e0130103. PubMed ID: 26098311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.